Achaogen Inc (AKAOQ)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: AKAOQ Exchange: OTC


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-03-20 2019-03-20 S Sale

DUGGAN ROBERT W

Large shareholder
50,000 -0.9%
0.53
USD 26,500 		50,000 -0.9% 0.53 USD 26,500
2019-03-20 2019-03-19 S Sale

DUGGAN ROBERT W

Large shareholder
956,009 -14.6%
0.53
USD 506,685 		956,009 -14.6% 0.53 USD 506,685
2019-03-20 2019-03-18 S Sale

DUGGAN ROBERT W

Large shareholder
271,879 -4.0%
0.56
USD 152,252 		271,879 -4.0% 0.56 USD 152,252
2019-03-13 2019-03-13 S Sale

DUGGAN ROBERT W

Large shareholder
1,199,930 -14.9%
0.59
USD 707,959 		1,199,930 -14.9% 0.59 USD 707,959
2019-03-13 2019-03-12 S Sale

DUGGAN ROBERT W

Large shareholder
633,975 -7.3%
0.61
USD 386,725 		633,975 -7.3% 0.61 USD 386,725
2019-03-13 2019-03-11 S Sale

DUGGAN ROBERT W

Large shareholder
520,102 -5.7%
0.63
USD 327,664 		520,102 -5.7% 0.63 USD 327,664
2019-02-25 2019-02-21 S Sale

Bhatt Elizabeth

Chief Operating Officer

Officer
971 -0.4%
0.89
USD 864 		971 -0.4% 0.89 USD 864
2019-02-25 2019-02-21 S Sale

Dorling Janet

Chief Commercial Officer

Officer
1,063 -0.4%
0.89
USD 946 		1,063 -0.4% 0.89 USD 946
2019-02-25 2019-02-21 S Sale

Wise Blake

Chief Executive Officer

Officer
3,771 -0.7%
0.89
USD 3,356 		3,771 -0.7% 0.89 USD 3,356
2019-02-25 2019-02-21 S Sale

LOEB GARY

See Remarks

Officer
791 -0.3%
0.89
USD 704 		791 -0.3% 0.89 USD 704
2019-02-25 2019-02-21 S Sale

Sarpangal Zeryn

Chief Financial Officer

Officer
1,388 -0.6%
0.89
USD 1,235 		1,388 -0.6% 0.89 USD 1,235
2019-02-07 2019-02-05 S Sale

Dorling Janet

Chief Commercial Officer

Officer
818 -0.3%
1.35
USD 1,104 		818 -0.3% 1.35 USD 1,104
2018-12-12 2018-12-11 B Purchase

DUGGAN ROBERT W

Large shareholder
306,848 +3.5%
1.65
USD 505,010 		306,848 +3.5% 1.65 USD 505,010
2018-12-12 2018-12-10 B Purchase

DUGGAN ROBERT W

Large shareholder
436,500 +5.2%
1.60
USD 697,789 		436,500 +5.2% 1.60 USD 697,789
2018-12-11 2018-12-07 B Purchase

DUGGAN ROBERT W

Large shareholder
22,431 +0.3%
1.40
USD 31,394 		22,431 +0.3% 1.40 USD 31,394
2018-11-27 2018-11-27 B Purchase

DUGGAN ROBERT W

Large shareholder
77,585 +0.9%
1.68
USD 129,963 		77,585 +0.9% 1.68 USD 129,963
2018-11-27 2018-11-23 B Purchase

DUGGAN ROBERT W

Large shareholder
80,175 +1.0%
1.89
USD 151,643 		80,175 +1.0% 1.89 USD 151,643
2018-11-23 2018-11-20 B Purchase

DUGGAN ROBERT W

Large shareholder
231,495 +2.9%
1.93
USD 446,947 		231,495 +2.9% 1.93 USD 446,947
2018-11-20 2018-11-19 B Purchase

DUGGAN ROBERT W

Large shareholder
4,648 +0.1%
1.62
USD 7,525 		4,648 +0.1% 1.62 USD 7,525
2018-09-27 2018-09-25 S Sale

LOEB GARY

General Counsel

Officer
1,038 -4.3%
4.15
USD 4,308 		1,038 -4.3% 4.15 USD 4,308
2018-09-27 2018-09-25 S Sale

Wise Blake

Chief Operating Officer

Officer
3,242 -3.4%
4.15
USD 13,454 		3,242 -3.4% 4.15 USD 13,454
2018-06-28 2018-06-26 PS Planned sale

Dorling Janet

Chief Commercial Officer
450 -1.9%
9.59
USD 4,316 		450 -1.9% 9.59 USD 4,316
2018-06-28 2018-06-26 PS Planned sale

Wise Blake

Chief Executive Officer

Executive Director
1,194 -1.2%
9.59
USD 11,450 		1,194 -1.2% 9.59 USD 11,450
2018-06-28 2018-06-26 PS Planned sale

Hillan Kenneth J.

See Remarks

Executive Director
744 -0.6%
9.59
USD 7,135 		744 -0.6% 9.59 USD 7,135
2018-06-28 2018-06-26 PS Planned sale

LOEB GARY

General Counsel
324 -1.3%
9.59
USD 3,107 		324 -1.3% 9.59 USD 3,107
2018-06-28 2018-06-26 S Sale

Schilke Tobin

Chief Financial Officer
298 -0.6%
9.59
USD 2,858 		298 -0.6% 9.59 USD 2,858
2018-06-13 2018-06-11 PS Planned sale

Schilke Tobin

Chief Financial Officer
2,087 -4.2%
11.95
USD 24,940 		2,087 -4.2% 11.95 USD 24,940
2018-05-07 2018-05-03 B Purchase

DUGGAN ROBERT W

Large shareholder
100,255 +inf%
11.43
USD 1,146,316 		100,255 +inf% 11.43 USD 1,146,316
2018-05-07 2018-05-03 B Purchase

DUGGAN ROBERT W

Large shareholder
30,000 +inf%
11.54
USD 346,338 		30,000 +inf% 11.54 USD 346,338
2018-05-07 2018-05-03 B Purchase

DUGGAN ROBERT W

Large shareholder
846,625 +11.8%
11.31
USD 9,579,477 		846,625 +11.8% 11.31 USD 9,579,477
2018-04-27 2018-04-27 B Purchase

DUGGAN ROBERT W

Large shareholder
102,849 +1.5%
12.96
USD 1,333,160 		102,849 +1.5% 12.96 USD 1,333,160
2018-04-27 2018-04-26 B Purchase

DUGGAN ROBERT W

Large shareholder
50,000 +0.7%
12.96
USD 647,755 		50,000 +0.7% 12.96 USD 647,755
2018-04-27 2018-04-25 B Purchase

DUGGAN ROBERT W

Large shareholder
77,247 +1.1%
13.02
USD 1,005,949 		77,247 +1.1% 13.02 USD 1,005,949
2018-04-23 2018-04-23 B Purchase

DUGGAN ROBERT W

Large shareholder
132,487 +1.9%
13.07
USD 1,730,969 		132,487 +1.9% 13.07 USD 1,730,969
2018-04-23 2018-04-20 B Purchase

DUGGAN ROBERT W

Large shareholder
216,150 +3.3%
13.23
USD 2,860,421 		216,150 +3.3% 13.23 USD 2,860,421
2018-04-23 2018-04-19 B Purchase

DUGGAN ROBERT W

Large shareholder
119,700 +1.8%
12.76
USD 1,527,264 		119,700 +1.8% 12.76 USD 1,527,264
2018-04-04 2018-04-04 B Purchase

DUGGAN ROBERT W

Large shareholder
47,361 +0.7%
12.44
USD 588,977 		47,361 +0.7% 12.44 USD 588,977
2018-04-04 2018-04-03 B Purchase

DUGGAN ROBERT W

Large shareholder
24,100 +0.4%
12.46
USD 300,240 		24,100 +0.4% 12.46 USD 300,240
2018-04-04 2018-04-02 B Purchase

DUGGAN ROBERT W

Large shareholder
20,000 +0.3%
12.51
USD 250,202 		20,000 +0.3% 12.51 USD 250,202
2018-03-30 2018-03-28 B Purchase

DUGGAN ROBERT W

Large shareholder
30,000 +0.5%
12.44
USD 373,095 		30,000 +0.5% 12.44 USD 373,095
2018-03-21 2018-03-20 B Purchase

DUGGAN ROBERT W

Large shareholder
25,000 +0.4%
11.09
USD 277,155 		25,000 +0.4% 11.09 USD 277,155
2018-03-21 2018-03-19 B Purchase

DUGGAN ROBERT W

Large shareholder
11,300 +0.2%
11.20
USD 126,557 		11,300 +0.2% 11.20 USD 126,557
2018-03-16 2018-03-15 B Purchase

DUGGAN ROBERT W

Large shareholder
30,000 +0.5%
11.23
USD 336,756 		30,000 +0.5% 11.23 USD 336,756
2018-03-16 2018-03-14 B Purchase

DUGGAN ROBERT W

Large shareholder
19,660 +0.3%
11.57
USD 227,488 		19,660 +0.3% 11.57 USD 227,488
2018-03-15 2018-03-13 S Sale

Hillan Kenneth J.

See Remarks

Executive Director
2,735 -2.8%
11.74
USD 32,109 		2,735 -2.8% 11.74 USD 32,109
2018-03-13 2018-03-12 B Purchase

DUGGAN ROBERT W

Large shareholder
20,000 +0.3%
11.39
USD 227,802 		20,000 +0.3% 11.39 USD 227,802
2018-03-13 2018-03-09 B Purchase

DUGGAN ROBERT W

Large shareholder
50,000 +0.8%
11.41
USD 570,520 		50,000 +0.8% 11.41 USD 570,520
2018-03-02 2018-03-02 B Purchase

DUGGAN ROBERT W

Large shareholder
96,790 +1.6%
10.14
USD 981,683 		96,790 +1.6% 10.14 USD 981,683
2018-03-02 2018-03-01 B Purchase

DUGGAN ROBERT W

Large shareholder
410,606 +7.2%
10.33
USD 4,243,285 		410,606 +7.2% 10.33 USD 4,243,285
2018-03-02 2018-02-28 B Purchase

DUGGAN ROBERT W

Large shareholder
20,000 +0.4%
10.70
USD 213,928 		20,000 +0.4% 10.70 USD 213,928
2018-02-23 2018-02-21 PS Planned sale

Wise Blake

Chief Executive Officer

Executive Director
1,640 -2.4%
10.67
USD 17,499 		1,640 -2.4% 10.67 USD 17,499
2018-02-23 2018-02-21 PS Planned sale

Schilke Tobin

Chief Financial Officer

Officer
1,108 -2.7%
10.67
USD 11,822 		1,108 -2.7% 10.67 USD 11,822
2018-02-23 2018-02-21 PS Planned sale

Swem Lee

Chief Scientific Officer

Officer
1,282 -3.4%
10.67
USD 13,679 		1,282 -3.4% 10.67 USD 13,679
2018-02-23 2018-02-21 PS Planned sale

Hillan Kenneth J.

See Remarks

Executive Director
4,606 -4.5%
10.67
USD 49,146 		4,606 -4.5% 10.67 USD 49,146
2018-02-15 2018-02-14 B Purchase

DUGGAN ROBERT W

Large shareholder
9,442 +0.2%
10.96
USD 103,487 		9,442 +0.2% 10.96 USD 103,487
2018-02-15 2018-02-13 B Purchase

DUGGAN ROBERT W

Large shareholder
558 +0.0%
10.97
USD 6,119 		558 +0.0% 10.97 USD 6,119
2018-01-05 2018-01-05 B Purchase

DUGGAN ROBERT W

Large shareholder
50,000 +0.9%
11.51
USD 575,500 		50,000 +0.9% 11.51 USD 575,500
2018-01-05 2018-01-03 B Purchase

DUGGAN ROBERT W

Large shareholder
15,000 +0.3%
10.89
USD 163,353 		15,000 +0.3% 10.89 USD 163,353
2017-12-20 2017-12-18 B Purchase

DUGGAN ROBERT W

Large shareholder
95,012 +1.7%
11.13
USD 1,057,493 		95,012 +1.7% 11.13 USD 1,057,493
2017-09-28 2017-09-26 S Sale

LOEB GARY

General Counsel
1,146 -7.9%
15.99
USD 18,325 		1,146 -7.9% 15.99 USD 18,325
2017-09-28 2017-09-26 S Sale

Wise Blake

President & COO
3,576 -5.1%
15.99
USD 57,180 		3,576 -5.1% 15.99 USD 57,180
2018-05-15 2017-09-25 S Sale

Swem Lee

Chief Scientific Officer

Officer
900 -2.4%
15.99
USD 14,391 		900 -2.4% 15.99 USD 14,391
2017-06-14 2017-06-12 PS Planned sale

Schilke Tobin

Chief Financial Officer
2,066 -4.9%
21.53
USD 44,481 		2,066 -4.9% 21.53 USD 44,481
2017-03-16 2017-03-14 S Sale

Hillan Kenneth J.

Chief Executive Officer

Executive Director
3,079 -3.0%
26.58
USD 81,840 		3,079 -3.0% 26.58 USD 81,840
2017-02-23 2017-02-21 S Sale

Sarpangal Zeryn

See Remarks
439 -2.6%
22.76
USD 9,992 		439 -2.6% 22.76 USD 9,992
2017-02-23 2017-02-21 S Sale

Friedland Ian

SVP, Chief Medical Officer
1,026 -2.7%
22.76
USD 23,352 		1,026 -2.7% 22.76 USD 23,352
2017-02-23 2017-02-21 S Sale

Hillan Kenneth J.

Chief Executive Officer

Executive Director
1,696 -2.7%
22.76
USD 38,601 		1,696 -2.7% 22.76 USD 38,601
2017-01-30 2017-01-26 PS Planned sale

Hillan Kenneth J.

Chief Executive Officer

Executive Director
1,431 -2.2%
16.78
USD 24,012 		1,431 -2.2% 16.78 USD 24,012
2017-01-30 2017-01-26 PS Planned sale

Friedland Ian

Chief Medical Officer

<